SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19

Clinical trial NCT04355494 · NO_LONGER_AVAILABLE

Trial details

NCT number: NCT04355494
Sponsor: Alexion Pharmaceuticals, Inc.
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS

COVID-19 Pneumonia, Viral Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.